Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
SDK2
Entity type
gene
Source
Source Link
Details
PrimaryID
54549
RefseqGene
Symbol
SDK2
Name
sidekick cell adhesion molecule 2
Chromosome
17
Location
17q25.1
TaxID
9606
Status
live
SourceGenome
genomic
SourceOrigin
natural
CreationDate
2000-08-26
ModificationDate
2021-06-11
Ontological Relatives
UniProt IDs
SDK2_HUMAN
GO terms
Show/Hide Table
GO
Name
GO:0005886
plasma membrane
GO:0007156
homophilic cell adhesion via plasma membrane adhesion molecules
GO:0007416
synapse assembly
GO:0010842
retina layer formation
GO:0016021
integral component of membrane
GO:0045202
synapse
GO:0045216
cell-cell junction organization
GO:0060219
camera-type eye photoreceptor cell differentiation
Diseases
Show/Hide Table
Interactions
28 interactions
Interactor
Partner
Sources
Publications
Link
SDK2
VMAC
BioGRID, IntAct
32296183
details
SDK2
PDZK1
IntAct
30126976
details
SDK2
BRCA1
BioGRID
22990118
details
SDK2
SRPK2
BioGRID
26167880
details
SDK2
TMEM30B
BioGRID, IntAct
28514442
details
SDK2
IL13RA2
BioGRID, IntAct
28514442
details
SDK2
PCDHGB1
BioGRID, IntAct
28514442
details
SDK2
SIGLECL1
BioGRID, IntAct
28514442
details
SDK2
LGALS3
BioGRID, IntAct
26186194
28514442
details
SDK2
RAET1E
BioGRID, IntAct
28514442
details
SDK2
CLU
BioGRID, IntAct
28514442
details
SDK2
CEACAM21
BioGRID, IntAct
26186194
28514442
details
SDK2
ADAM17
BioGRID, IntAct
28514442
details
SDK2
TANK
BioGRID, IntAct
30561431
details
SDK2
FADD
BioGRID, IntAct
30561431
details
SDK2
TNFAIP3
BioGRID, IntAct
30561431
details
SDK2
CD9
UniProt
26686862
details
SDK2
TSPAN5
UniProt
26686862
details
SDK2
TSPAN15
UniProt
26686862
details
SDK2
RBX1
BioGRID
30349055
details
SDK2
GJA1
BioGRID
34079125
details
SDK2
KRAS
BioGRID
34079125
details
SDK2
LYN
BioGRID
34079125
details
SDK2
AFDN
BioGRID
34079125
details
SDK2
OCLN
BioGRID
34079125
details
SDK2
RAB11A
BioGRID
34079125
details
SDK2
RHOB
BioGRID
34079125
details
SDK2
STX7
BioGRID
34079125
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree